Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM
Cheng Tian, Xuewen Min, Yongxu Zhao, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1491-1503
Closed Access | Times Cited: 25

Showing 25 citing articles:

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
Xiumei Wu, Mengyun Xu, M. Geng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 99
Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
Zahra Dashti, Zeynab Yousefi, Pouria Kiani, et al.
Metabolism (2024) Vol. 154, pp. 155811-155811
Closed Access | Times Cited: 19
Non-alcoholic fatty liver disease: pathogenesis and models
Hanxiang Zhong
American Journal of Translational Research (2024) Vol. 16, Iss. 2, pp. 387-399
Open Access | Times Cited: 13
Decoding CKD-induced muscle atrophy through the critical role of lncRNA GAS5 and pyroptosis
Rong Huang, Xiaolu Tang, Shuang Liu, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102451-102451
Open Access | Times Cited: 1
MRG15 aggravates sepsis-related liver injury by promoting PCSK9 synthesis and secretion
Boyuan Gu, Yu Jiang, Zhiwei Huang, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112898-112898
Open Access | Times Cited: 5
Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target
Chao Xu, Litao Liang, Guoqing Liu, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Marine natural products as an important source of bioactive substances for non-alcoholic fatty liver disease management
Menglei Shi, Sisi Chen, Feng Yuan, et al.
Frontiers in Marine Science (2025) Vol. 11
Open Access
LocPro: a deep learning-based prediction of protein subcellular localization for promoting multi-directional pharmaceutical research
Yintao Zhang, Lingyan Zheng, Nanxin You, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101255-101255
Open Access
Dimethyl fumarate modulates M1/M2 macrophage polarization to ameliorate periodontal destruction by increasing TUFM-mediated mitophagy
Liang Chen, Ping Hu, Xinhua Hong, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Emerging and potential use of CRISPR in human liver disease
Salah Adlat, Alexandra M. Vázquez-Salgado, Markcus Lee, et al.
Hepatology (2023)
Closed Access | Times Cited: 9
Structural and functional insights into the epigenetic regulator MRG15
Nan Jiang, Yongbo Li, Jiayu Jin, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 879-889
Closed Access | Times Cited: 3
Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
Jiaxin Chen, Linge Jian, Yangkun Guo, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 729-729
Open Access | Times Cited: 3
Tufm lactylation regulates neuronal apoptosis by modulating mitophagy in traumatic brain injury
Weiji Weng, Zhenghui He, Zixuan Ma, et al.
Cell Death and Differentiation (2024)
Closed Access | Times Cited: 3
Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
Yu Mou, Wenhao Liao, Yuchen Li, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 02, pp. 315-354
Closed Access | Times Cited: 2
TUFM in health and disease: exploring its multifaceted roles
Ning Liu, Bo Pang, Longfei Kang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review
Yalan Deng, Yuan Dong, Sitian Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
IRF1-mediated upregulation of PARP12 promotes cartilage degradation by inhibiting PINK1/Parkin dependent mitophagy through ISG15 attenuating ubiquitylation and SUMOylation of MFN1/2
Zengfa Deng, Dianbo Long, Changzhao Li, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Emerging roles of MRG15 in liver metabolic diseases
Cheng Tian, Xiaosong Gu, Chunping Jiang, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 527-529
Closed Access | Times Cited: 1
Mitochondrial dysfunction and onset of type 2 diabetes along with its complications: a multi-omics Mendelian randomization and colocalization study
Yang Li, Yahu Miao, Qing Feng, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Loss of TMEM55B modulates lipid metabolism through dysregulated lipophagy and mitochondrial function
Yuanyuan Qin, Sheila Teker, Nilsa La Cunza, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis
Yibing Wang, Hanhan Yu, Zhipeng Cen, et al.
Metabolism Open (2023) Vol. 21, pp. 100267-100267
Open Access | Times Cited: 1
The new epigenetic driver role of PPARα and mitochondria in metabolic dysfunction associated liver disease (MASLD), paving the way towards new therapeutics and diagnostic biomarkers
Claudia Theys
(2024)
Open Access
MRG15 promotes cell apoptosis through inhibition of mitophagy in hyperlipidemic acute pancreatitis
Boyuan Gu, Wenhao Yu, Zhiwei Huang, et al.
APOPTOSIS (2024)
Closed Access
Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids
Xiaoshan Wu, Dacheng Jiang, Yuchen Wang, et al.
Hepatology Communications (2024) Vol. 8, Iss. 12
Open Access
Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
Yao Zhang, Μaria Dalamaga, Junli Liu
Metabolism Open (2022) Vol. 16, pp. 100217-100217
Open Access | Times Cited: 1
Page 1

Scroll to top